Kenya National Cancer Control Programme (NCCP) Implementation Guide - Local Development build (v1.0.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
{
"resourceType" : "Procedure",
"id" : "PriorRadiotherapyProcedureExample",
"meta" : {
"profile" : [
🔗 "https://fhir.dha.go.ke/nccp/StructureDefinition/nccp-prior-radiotherapy-procedure"
]
},
"language" : "en",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Prior concurrent chemoradiotherapy (CCRT) for locally advanced cervical cancer in 2023</p></div>"
},
"status" : "completed",
"category" : {
"coding" : [
{
"system" : "https://fhir.dha.go.ke/terminology/CodeSystem/sha-interventions-cs",
"code" : "SHA-RT-CONCURRENT-CRT",
"display" : "SHA: Concurrent Chemo-Radiotherapy"
}
]
},
"code" : {
"coding" : [
{
"system" : "https://fhir.dha.go.ke/terminology/CodeSystem/sha-interventions-cs",
"code" : "SHA-RT-CONCURRENT-CRT",
"display" : "SHA: Concurrent Chemo-Radiotherapy"
}
]
},
"subject" : {
🔗 "reference" : "Patient/example-patient"
},
"performedPeriod" : {
"start" : "2023-03-01",
"end" : "2023-04-15"
},
"bodySite" : [
{
"coding" : [
{
"system" : "https://fhir.dha.go.ke/terminology/CodeSystem/cancer-primary-site-cs",
"code" : "CERVIX-UTERI",
"display" : "Cervix Uteri"
}
]
}
],
"note" : [
{
"text" : "External beam RT 45 Gy/25 fractions plus brachytherapy boost. Concurrent weekly cisplatin 40 mg/m²."
}
]
}